Gregory Lubiniecki is an Oncology physician affiliated with Merck & Co.. OpenAlex indexes 69 publications with 33,419 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
333 Cottman Ave
Philadelphia, PA 191112434
Telephone
215-728-2500Registry record last updated 9 Apr 2018.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
Expert Review of Anticancer Therapy
2022 - Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
The Lancet Respiratory Medicine
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Luther Clark, MD
Merck & Co.
Alfred Saah, MD
Merck & Co.
Keith Kaufman, MD
Merck & Co.
Aristide Merola, MD
Merck & Co.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”